Skip to main content

WPI 2287 (Propafenone Hydrochloride Extended-Release 425 mg)

Pill with imprint WPI 2287 is White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended-Release 425 mg. It is supplied by Actavis Pharma, Inc.

Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; atrial flutter; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2287

Propafenone Hydrochloride Extended-Release

Imprint
WPI 2287
Strength
425 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-2287
Inactive Ingredients
ferrosoferric oxide, gelatin, hypromelloses, magnesium stearate, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.